Selective Androgen Receptor Modulators - A Review of Potential Uses, Benefits, Side effects and Limitations
DOI:
https://doi.org/10.12775/JEHS.2023.45.01.030Keywords
selective androgen receptor modulators, androgens, sportsAbstract
Introduction: Selective Androgen Receptor Modulators (SARMs) are a group of chemical compounds capable of selectively activating androgen receptors (ARs) in the body. These substances can play a significant role in a new therapeutic approach in various fields of medicine, limiting the side effects associated with traditional anabolic steroids. In this article, we will focus on an overview of the current scientific knowledge on SARMs, their mechanisms of action, potential therapeutic applications, risks and challenges related to their use.
Aim of the study: The primary aim of this study was to to present potential use of selective androgen receptor modulators in sport and treatment focusing on its benefits and limitations as well as side effects aspects.
State of Knowledge: SARMs in research show therapeutic benefits in the treatment of diseases such as osteoporosis, benign prostatic hyperplasia, muscle diseases and some types of cancer. Some studies suggest that few SARMs may be hepatotoxic. Most research on SARMs has been short-term, so the long-term effects of their use remain poorly understood.
Conclusion: The popularity of SARMs is constantly growing, and research on their use in medicine and sports provides more and more new ways to use them. Despite promising results, these compounds still pose many scientific challenges and raise legitimate concerns about their long-term effects on human health.
References
Jordan VC. Selective estrogen receptor modulation. Cancer Res 2001;61:5683–7.
Chen J. Discovery and Therapeutic Promise of Selective Androgen Receptor Modulators. Mol Interv 2005;5:173–88.
Crawford J, Prado CMM, Johnston MA, Gralla RJ, Taylor RP, Hancock ML, et al. Study Design and Rationale for the Phase 3 Clinical Development Program of Enobosarm, a Selective Androgen Receptor Modulator, for the Prevention and Treatment of Muscle Wasting in Cancer Patients (POWER Trials). Curr Oncol Rep 2016;18:37.
Dalton JT, Barnette KG, Bohl CE, Hancock ML, Rodriguez D, Dodson ST, et al. The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: Results of a double-blind, placebo-controlled phase II trial. J Cachexia Sarcopenia Muscle 2011;2:153–61.
M.F. Z. Nonsteroidal selective androgen receptor modulator OstarineTM in cancer cachexia. Futur Oncol 2009;5:1211–20.
Dubois V, Simitsidellis I, Laurent MR, Jardi F, Saunders PTK, Vanderschueren D, et al. Enobosarm (GTx-024) modulates adult skeletal muscle mass independently of the androgen receptor in the satellite cell lineage. Endocrinology 2015;156:4522–33.
Narayanan R, Coss CC, Dalton JT. Development of selective androgen receptor modulators (SARMs). Mol Cell Endocrinol. 2018 Apr 15;465:134-142. doi: 10.1016/j.mce.2017.06.013. Epub 2017 Jun 15.
Davey RA, Grossmann M. Androgen Receptor Structure, Function and Biology: From Bench to Bedside. Clin Biochem Rev. 2016 Feb;37(1):3-15.
Vignozzi L, Cellai I, Santi R, Lombardelli L, Morelli A, Comeglio P, et al. Antiinflammatory effect of androgen receptor activation in human benign prostatic hyperplasia cells. J Endocrinol 2012;214:31–43.
Vignozzi L, Morelli A, Sarchielli E, Comeglio P, Filippi S, Cellai I, et al. Testosterone protects from metabolic syndrome-associated prostate inflammation: An experimental study in rabbit. J Endocrinol 2012;212:71–84
Miller DD, Dalton JT. Comparison of the Pharmacological Effects of a Novel Selective Androgen Receptor Modulator, the 5 - Hydroxyflutamide in Intact Rats : New Approach for Benign Prostate Hyperplasia 2004;145:5420–8.
Narayanan R, Dalton JT. Androgen receptor: A complex therapeutic target for breast cancer. Cancers (Basel) 2016;8:1–17. doi: 10.3390/cancers8120108.
Vontela N, Koduri V, Schwartzberg LS, Vidal GA. Selective Androgen Receptor Modulator in a Patient With Hormone-Positive Metastatic Breast Cancer 2017;15:284–7.
Jones A, Hwang D-J, Narayanan R, Miller DD, Dalton JT. Effects of a novel selective androgen receptor modulator on dexamethasone-induced and hypogonadism-induced muscle atrophy. Endocrinology 2010;151:3706–19.
Ponnusamy S, Sullivan RD, You D, Zafar N, Yang CH, Thiyagarajan T, et al. Androgen receptor agonists increase lean mass, improve cardiopulmonary functions and extend survival in preclinical models of Duchenne muscular dystrophy. Hum Mol Genet 2017;26:2526–40.
Watanabe K, Hirata M, Tominari T, Matsumoto C, Endo Y, Murphy G, et al. BA321, a novel carborane analog that binds to androgen and estrogen receptors, acts as a new selective androgen receptor modulator of bone in male mice. Biochem Biophys Res Commun 2016;478:279–85.
Jones A, Hwang D-J, Narayanan R, Miller DD, Dalton JT. Effects of a novel selective androgen receptor modulator on dexamethasone-induced and hypogonadism-induced muscle atrophy. Endocrinology 2010;151:3706–19.
Solomon ZJ, Mirabal JR, Mazur DJ, Kohn TP, Lipshultz LI, Pastuszak AW. Selective Androgen Receptor Modulators: Current Knowledge and Clinical Applications. Sex Med Rev. 2019 Jan;7(1):84-94. doi: 10.1016/j.sxmr.2018.09.006. Epub 2018 Nov 30.
Thevis M Detection of the arylpropionamide-derived selective androgen receptor modulator (SARM) S-4 (Andarine) in a black-market product. Drug Test Anal 2009;1:387–92.
Best place to Buy SARMs Online - Quality SARMs for Sale | SarmsPharm n.d. https://sarmspharm.com/ (accessed October 20, 2017).
ESPN. 2022. [Internet]. Toronto: Reuters. cited 2022 Apr 26. https://www.espn.com/olympics/story/_/id/33321343/cj-ujah-positive-test-sees-team-gb-stripped-olympic-silver-medal
NBA. 2017. [Internet]. New York City: Associated Press. cited 2022 Apr 26 https://www.nba.com/news/joakim-noah-suspension-supplement-backfired
CBC [Internet]. Toronto: CBC Sports; 2020 cited 2022 Apr 26. https://www.cbc.ca/sports/olympics/summer/canoe-kayak/laurence-vincent-lapointe-doping-verdict-1.5441395
Hilkens L, Cruyff M, Woertman L, et al. Social media, body image and resistance training: creating the perfect ‘me’ with dietary supplements, anabolic steroids and SARM’s. Sports Med Open. 2021;7(1):81.
Shimko KM, Piatkowski T, Thomas KV, et al. Performance- and image-enhancing drug use in the community: use prevalence, user demographics and the potential role of wastewater-based epidemiology. J Hazard Mater. 2021;419:126340.
Efimenko IV, Chertman W, Masterson TA, et al. Analysis of the growing public interest in selective androgen receptor modulators. Andrologia. 2021;53(11):e14238.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Kamil Ostafin, Krzysztof Edyko, Piotr Petryla, Mikołaj Minkner, Borys Bienkowski, Krzysztof Feja, Zuzanna Suwała, Natalia Rektor, Ewa Łuczak, Urszula Marchewka
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 498
Number of citations: 0
